Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BND vs GSK✓SelectedUSD · GSKBND vs GSK performance historyLatest closeAs of+0.13%11/17
Stock and ETF performance explorer

BND vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+17.8%
GSK return
+104.0%
Excess return
-86.2%
Maximum drawdown
-18.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.1%-2.3%+2.4%+0.2%
7D-0.6%-3.0%+2.4%-0.5%
30D+0.2%+0.4%-0.1%+0.2%
3M-1.0%-1.2%+0.2%-0.9%
6M-0.7%+0.9%-1.7%-0.8%
YTD-1.2%+4.0%-5.2%-1.5%
1Y-0.8%+7.3%-8.1%-1.2%
3Y+12.3%+57.1%-44.8%+9.9%
5Y-1.3%+43.0%-44.3%-3.5%
10Y+17.8%+103.1%-85.3%+14.0%
All+17.8%+104.0%-86.2%+14.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling